Xian-Meng Li
Overview
Explore the profile of Xian-Meng Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
39
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Li Q, Tang Y, Li Y, Zhang L, Xu F, et al.
Acta Pharmacol Sin
. 2024 Jun;
45(12):2625-2645.
PMID: 38942954
C/EBP homologous protein (CHOP) triggers the death of multiple cancers via endoplasmic reticulum (ER) stress. However, the function and regulatory mechanism of CHOP in liver cancer remain elusive. We have...
2.
Zhang L, Li X, Shi X, Ye K, Fu X, Wang X, et al.
Acta Pharmacol Sin
. 2022 Sep;
44(3):622-634.
PMID: 36109580
Sorafenib, which inhibits multiple kinases, is an effective frontline therapy for hepatocellular carcinoma (HCC). Ferroptosis is a form of iron-dependent programmed cell death regulated by lipid peroxidation, which can be...
3.
Xu F, Sun H, Fang R, Zhang L, Shi H, Wang X, et al.
Acta Pharmacol Sin
. 2021 Apr;
43(2):429-445.
PMID: 33824459
Programmed death ligand-1 (PD-L1)/PD-1 checkpoint extensively serves as a central mediator of immunosuppression. A tumor-promoting role for abundant PD-L1 in several cancers is revealed. However, the importance of PD-L1 and...